Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2525)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5695)
  2. Department of Medicine (5685)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (203)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Grüllich, C.; Rini, B. I.; Huseni, M.; Atkins, M.; McDermott, D.; Powles, T.; Escudier, B.; Banchereau, R.; Liu, L. F.; Leng, N.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • CheckMate 214 patients who discontinued first-line nivolumab + ipilimumab or sunitinib due to treatment-related adverse events
    Meeting Abstract

    Grünwald, V.; Tannir, N. M.; Motzer, R. J.; Plimack, E. R.; McDermott, D. F.; Barthélémy, P.; Porta, C.; George, S.; Powles, T.; Donskov, F.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Pathogenic loss-of-function germline TERT mutations in patients with solid tumors
    Journal Article

    Walsh, M. F.; Sacca, R.; Wildman, T.; Amoroso, K.; Kennedy, J.; Zhang, L.; Birsoy, O.; Mandelker, D.; Steinsnyder, Z.; Latham, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Targeting nucleotide excision repair defects in cancer
    Meeting Abstract

    Topka, S.; Steinsnyder, Z.; Tkachuk, K.; Ravichandran, V.; Madsen, M. W.; Furberg-Barnes, H.; Iyer, G.; De Stanchina, E.; Joseph, V.; Offit, K.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: A randomized clinical trial
    Journal Article

    Garland, S. N.; Xie, S. X.; DuHamel, K.; Bao, T.; Li, Q.; Barg, F. K.; Song, S.; Kantoff, P.; Gehrman, P.; Mao, J. J.
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • "Primary" and "secondary" muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
    Correspondence

    Pietzak, E. J.; Al-Ahmadie, H.; Walasek, A.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B. H.; Solit, D. B.; Iyer, G.
    Translational Cancer Research (2019)

    Fulltext@MSK | Save
  • EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Petrylak, D. P.; Rosenberg, J. E.; Lee, J.; Yonese, J.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E. M.; Melhem-Bertrandt, A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Eligibility and radiologic assessment in adjuvant clinical trials in bladder cancer
    Review

    Apolo, A. B.; Milowsky, M. I.; Kim, L.; Inman, B. A.; Kamat, A. M.; Steinberg, G.; Bagheri, M.; Krishnasamy, V. P.; Marko, J.; Dinney, C. P.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
    Guidelines

    Rini, B. I.; Battle, D.; Figlin, R. A.; George, D. J.; Hammers, H.; Hutson, T.; Jonasch, E.; Joseph, R. W.; McDermott, D. F.; Motzer, R. J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save